Key points are not available for this paper at this time.
To examine the long-term safety and tolerability of off-label high-dose serotonin reuptake inhibitors (OLHD-SRIs) in the treatment of obsessive-compulsive disorder (OCD).
Levy et al. (Mon,) studied this question.